Veredus Laboratories Pte Ltd is pleased to announce its acquisition by SEKISUI CHEMICAL CO., LTD1.
Founded in 2003, Veredus Laboratories Pte Ltd (hereinafter, “Veredus”) specializes in the development, manufacturing and marketing of innovative multiplexed molecular solutions in the clinical, specialty, and custom testing markets based on STMicroelectronics’ Lab-on-Chip platform. The Lab-on-Chip platform, also known as the VerePLEX™ Biosystem, combines Micro-Electro Mechanical Systems (MEMS) with micro-fluidics to integrate multiplexed DNA amplification with microarray detection for rapid, cost-effective, and accurate analysis of biological materials.
With this acquisition, Veredus will continue to carry its own product line and also welcome the medical products from SEKISUI MEDICAL CO., LTD., a company which is 100% subsidiary of SEKISUI CHEMICAL CO., LTD.
Dr Rosemary Tan will continue to lead Veredus as its Chief Executive Officer, and Veredus remains fully committed in bringing innovative technologies and quality products to our customers.
1Refer to Official Press Release by SEKISUI CHEMICAL CO., LTD, dated 3rd April, 2018
VereFever™ is able to detect, differentiate and identify 7 different major tropical diseases from a single blood sample, including Malaria, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis and Zika by using the STMicroelectronics proprietary Lab-on-Chip platform that integrates two powerful molecular biological applications, Polymerase Chain Reaction (PCR) and a microarray.
The fingernail-size microchip, VereFever Chip can detect Malaria, Chikungunya, West Nile, Yellow Fever, Japanese encephalitis, Dengue and Zika from just a drop of blood.
Researchers at hospitals and universities in five European countries and in Tanzania collaborated to evaluate the performance of VereMTB™ on 91 clinical isolates harbouring different resistance-conferring mutations. They reported a diagnostic accuracy of about 98 percent compared to sequencing and another assay, GenoType MTBDRplus from Hain Lifescience.
The Agri-Food and Veterinary Authority of Singapore (AVA) and Veredus Laboratories has jointly launched VereVet™, a portable Lab-on-Chip application that is able to detect, differentiate and identify nine major poultry infectious disease agents from one sample in one single test.
VerePLEX™ Biosystem has been selected by the Brazilian civil security forces as a system to monitor and identify potential biological threats during the FIFA World Cup 2014.
Veredus has successfully developed VereMERS™, a Lab-on-Chip application that is able to detect, from a sequence perspective, Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Veredus has appointed Mediwell Enterprise Pte Ltd as a distributor for Malaysia, Myanmar and Vietnam.
The Agency for Science, Technology and Research (A*STAR) and VeredusLaboratories announced the launch of VereTrop™, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases, from a single blood sample.
Veredus has appointed Xgenex as a distributor in U.S.A.